Skip to main content

Juan León Román

Institutions of which they are part

Predoctoral researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Juan León Román

Institutions of which they are part

Predoctoral researcher
Nephrology and kidney transplantation
Vall Hebron Institut de Recerca

Projects

ROL DE LA APELINA EN LA ENFERMEDAD RENAL DIABÉTICA: DEL RATÓN AL HUMANO

IP: Maria Jose Soler Romeo
Collaborators: Marina Lopez Martinez, Jordi Vilardell Vilà, Irene Martinez Diaz, Sheila Bermejo Garcia, Vicent Muñoz Vaño, Carmen Llorens Cebriá, M Antonieta Azancot Rivero, Enzamaría Fidilio Meli, Juan Carlos León Román
Funding agency: Instituto de Salud Carlos III
Funding: 190000
Reference: PI24/01510
Duration: 01/01/2025 - 31/12/2027

Unravelling the protective pathways of the SGLT2i and GLP-1RA in diabetic kidney disease: Role of the MAP17 and D-AKAP-2 scaffolder proteins in db/db mice and in human kidney organoids.

IP: Maria Jose Soler Romeo
Collaborators: Juan Carlos León Román, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 65000
Reference: CM23/00213
Duration: 15/01/2024 - 14/01/2026

Desentrañando las vías protectoras de los SGLT2i y GLP-1RA en la enfermedad renal diabética: papel de las proteínas adaptadoras MAP17 y D-AKAP-2 en ratones db/db y organoides renales humanos.

IP: Maria Jose Soler Romeo
Collaborators: Mario Alonso Narvaez Barros, Pamela Dominguez Baez, Sheila Bermejo Garcia, Alejandra Planas Vilaseca, Concepció Jacobs Cachá, Juan Carlos León Román, Irene Martinez Diaz
Funding agency: Instituto de Salud Carlos III
Funding: 122210
Reference: PI21/01292
Duration: 01/01/2022 - 30/06/2026

Related news

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.

A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.

Related professionals

Rosario Pardo  Diaz

Rosario Pardo Diaz

Research technician
Diabetes and Metabolism
Read more
Gerard Marti Aguasca

Gerard Marti Aguasca

Cardiovascular Diseases
Read more
Marta Esteve  Costal

Marta Esteve Costal

Administrative
Purchase and Biddings Unit
Finance Directorate
Read more
Mónica Fernández Cancio

Mónica Fernández Cancio

Senior researcher
Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.